Filing Flows › Upstream Bio (UPB) › Stock forecast & fair value
Upstream Bio (UPB) stock forecast and price target
Upstream Bio (UPB) trades at $3.23. 6 analysts' median price target is $22.00 (+581%), from $9.00 to $75.00.
Upstream Bio's latest quarter
Upstream Bio, Q2 2026: revenue $773K (-18% year over year), net loss $39.7M, operating cash flow −$35.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for UPB stock?
The median of 6 analysts' 12-month targets is $22.00, +581% from $3.23; the range is $9.00 to $75.00. The average rating is none.
Does Upstream Bio usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is UPB stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.